The report is titled as ‘Mild Traumatic Brain Injury Treatment Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the mild traumatic brain injury treatment market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The mild traumatic brain injury treatment market is expected to grow at a significant rate in the near future.
The global mild traumatic brain injury treatment market in 2020 is estimated for more than US$ 65.8 Mn and expected to reach a value of US$ 93.0 Mn by 2028 with a significant CAGR of 4.4%.
The increasing number of road accidents, coupled with the growing number of vulnerable aging populations are major factors driving the growth of the global traumatic brain injuries treatment market. For instance, according to data published by the National Health of Mental illness, in January 2018, mental illness is common in the U.S; nearly 46.6 Mn U.S. adults were affected by mental disorders in 2017.
Increasing research activities on diagnosis management, coupled with a new pipeline of drugs are propelling the global traumatic brain injuries treatment market growth. An increase in the research and development by scientists in the U.S. FDA mainly for the study of various biomarkers of brain imaging, bio fluid and physical indicators for detection of traumatic brain injuries (TBI) is in a process which is expected to take a positive turn in the treatment pattern of TBI in patients with severe brain injuries which in turn boosting the growth of the global market.
Molecular targeted therapies such as BHR-100 (Progesterone Drug) is expected to introduce by BHR Pharma, LLC, rhuEpo, recombinant human erythropoietin is anticipated to propel global market growth over the forecast period.
However, lack of awareness among people, and lack of funding by the government in TBI treatment R&D are anticipated to restrain the growth of the global mild traumatic brain injury treatment market during the next decade. On the other hand, the high cost of treatment and monitoring devices may restrain the growth of the global market. Nevertheless, the large number of clinical trials is conducted worldwide in order to develop effective therapies for TBI which is creating opportunities for growth of the global market.
Mild traumatic brain injury treatment market is segmented on the basis of device type, technique, end-user, and by region.
• By Device Type:
Imaging Devices
Computed Tomography Devices
Magnetic Resonance Imaging
X-Ray
Others
Clinical Examination Devices
Monitoring Devices
Invasive Monitoring Devices
Non-Invasive Monitoring Devices
• By Technique:
Intracranial Pressure Monitoring (ICP)
Partial Pressure of Oxygen in Brain Tissue (pBrO2)
• By End-user:
Hospitals
Diagnostic Imaging Centers
Others
• By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
In the global mild traumatic brain injury treatment market, several drugs are in a pipeline including, Cycloserine, Fosaprepitant, Phenytoin, Sodium oxybate, Epoprostenol, Flortaucipir F-18, and Glyburide. These drugs are in the 0 and 1st phase of investigation respectively. After traumatic brain injury along with wide therapeutic window; Cycloserine improves functional outcome. Fosaprepitant is an intravenously administered antiemetic drug. It is a pro-drug of Aprepitant and aids in prevention of acute as well as delayed nausea and vomiting of chemotherapy treatment.
Source: Drugbank, 2019
Key players operating in the global mild traumatic brain injury treatment market include TEVA Pharmaceutical Industries Ltd., Neuren Pharmaceuticals Ltd, Tenax Therapeutics, IschemixInc, Grace Laboratories LLC., Silver Creek Pharmaceuticals Inc, Stemedica Cell Technologies Inc, NeuroScience Pharmaceuticals, Vasopharm GmbH, AmarantusBioScience Holdings, and Banayan Biomarkers Inc.
On the basis of region, the mild traumatic brain injury treatment market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Mild Traumatic Brain Injury Treatment market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Mild Traumatic Brain Injury Treatment
• Advantages of Mild Traumatic Brain Injury Treatment Drugs
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Mild Traumatic Brain Injury Treatment Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Mild Traumatic Brain Injury Treatment Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Mild Traumatic Brain Injury Treatment Market Snapshot
2.4. Global Mild Traumatic Brain Injury Treatment Market Size and Forecast, 2019–2027
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)
2.5. Global Mild Traumatic Brain Injury Treatment Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Mild Traumatic Brain Injury Treatment Market, By Devices Type
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Devices Type
3.1.2. BPS Analysis, By Devices Type
3.2. Market Revenue (US$Mn) Forecast, By Devices Type
3.2.1. Imaging Devices
3.2.1.1. Computed Tomography Devices
3.2.1.2. Magnetic Resonance Imaging
3.2.1.3. X-Ray
3.2.1.4. Others
3.2.2. Clinical Examination Devices
3.2.3. Monitoring Devices
3.2.3.1. Invasive Monitoring Devices
3.2.3.2. Non-Invasive Monitoring Devices
3.3. Global Mild Traumatic Brain Injury Treatment Market Attractiveness Index, By Devices Type
4. Global Mild Traumatic Brain Injury Treatment Market, By Technique
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Technique
4.1.2. BPS Analysis, By Technique
4.2. Market Revenue (US$Mn) Forecast, By Technique
4.2.1. Intracranial Pressure Monitoring (ICP)
4.2.2. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
4.3. Global Mild Traumatic Brain Injury Treatment Market Attractiveness Index, By Technique
5. Global Mild Traumatic Brain Injury Treatment Market, By End User
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By End User
5.1.2. BPS Analysis, By End User
5.2. Market Revenue (US$Mn) Forecast, By End User
5.2.1. Hospitals
5.2.2. Diagnostic Imaging Centers
5.2.3. Others
5.3. Global Mild Traumatic Brain Injury Treatment Market Attractiveness Index, By End User
6. Global Mild Traumatic Brain Injury Treatment Market, By Region
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Region
6.1.2. BPS Analysis, By Region
6.2. Market Revenue (US$Mn) Forecast, By Region
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. Asia Pacific
6.2.5. Middle East
6.2.6. Africa
6.3. Global Mild Traumatic Brain Injury Treatment Market Attractiveness Index, By Region
7. North America Mild Traumatic Brain Injury Treatment Market Analysis and Forecast, 2019–2027
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market Revenue (US$Mn) Forecast, By Country
7.2.1. U.S. Mild Traumatic Brain Injury Treatment Market
7.2.2. Canada Mild Traumatic Brain Injury Treatment Market
7.3. North America Mild Traumatic Brain Injury Treatment Market, By Devices Type
7.3.1. Imaging Devices
7.3.1.1. Computed Tomography Devices
7.3.1.2. Magnetic Resonance Imaging
7.3.1.3. X-Ray
7.3.1.4. Others
7.3.2. Clinical Examination Devices
7.3.3. Monitoring Devices
7.3.3.1. Invasive Monitoring Devices
7.3.3.2. Non-Invasive Monitoring Devices
7.4. North America Mild Traumatic Brain Injury Treatment Market, By Technique
7.4.1. Intracranial Pressure Monitoring (ICP)
7.4.2. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
7.5. North America Mild Traumatic Brain Injury Treatment Market, By End User
7.5.1. Hospitals
7.5.2. Diagnostic Imaging Centers
7.5.3. Others
7.6. North America Mild Traumatic Brain Injury Treatment Market Attractiveness Index
7.6.1. By Country
7.6.2. By Devices Type
7.6.3. By Technique
7.6.4. By End User
8. Latin America Mild Traumatic Brain Injury Treatment Market Analysis and Forecast, 2019–2027
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. Brazil Mild Traumatic Brain Injury Treatment Market
8.2.2. Mexico Mild Traumatic Brain Injury Treatment Market
8.2.3. Argentina Mild Traumatic Brain Injury Treatment Market
8.2.4. Rest of Latin America Mild Traumatic Brain Injury Treatment Market
8.3. Latin America Mild Traumatic Brain Injury Treatment Market, By Devices Type
8.3.1. Imaging Devices
8.3.1.1. Computed Tomography Devices
8.3.1.2. Magnetic Resonance Imaging
8.3.1.3. X-Ray
8.3.1.4. Others
8.3.2. Clinical Examination Devices
8.3.3. Monitoring Devices
8.3.3.1. Invasive Monitoring Devices
8.3.3.2. Non-Invasive Monitoring Devices
8.4. Latin America Mild Traumatic Brain Injury Treatment Market, By Technique
8.4.1. Intracranial Pressure Monitoring (ICP)
8.4.2. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
8.5. Latin America Mild Traumatic Brain Injury Treatment Market, By End User
8.5.1. Hospitals
8.5.2. Diagnostic Imaging Centers
8.5.3. Others
8.6. Latin America Mild Traumatic Brain Injury Treatment Market Attractiveness Index
8.6.1. By Country
8.6.2. By Devices Type
8.6.3. By Technique
8.6.4. By End User
9. Europe Mild Traumatic Brain Injury Treatment Market Analysis and Forecast, 2019–2027
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. U.K. Mild Traumatic Brain Injury Treatment Market
9.2.2. Germany Mild Traumatic Brain Injury Treatment Market
9.2.3. Italy Mild Traumatic Brain Injury Treatment Market
9.2.4. France Mild Traumatic Brain Injury Treatment Market
9.2.5. Spain Mild Traumatic Brain Injury Treatment Market
9.2.6. Russia Mild Traumatic Brain Injury Treatment Market
9.2.7. Poland Mild Traumatic Brain Injury Treatment Market
9.2.8. BENELUX Mild Traumatic Brain Injury Treatment Market
9.2.9. NORDIC Mild Traumatic Brain Injury Treatment Market
9.2.10. Rest of Europe Mild Traumatic Brain Injury Treatment Market
9.3. Europe Mild Traumatic Brain Injury Treatment Market, By Devices Type
9.3.1. Imaging Devices
9.3.1.1. Computed Tomography Devices
9.3.1.2. Magnetic Resonance Imaging
9.3.1.3. X-Ray
9.3.1.4. Others
9.3.2. Clinical Examination Devices
9.3.3. Monitoring Devices
9.3.3.1. Invasive Monitoring Devices
9.3.3.2. Non-Invasive Monitoring Devices
9.4. Europe Mild Traumatic Brain Injury Treatment Market, By Technique
9.4.1. Intracranial Pressure Monitoring (ICP)
9.4.2. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
9.5. Europe Mild Traumatic Brain Injury Treatment Market, By End User
9.5.1. Hospitals
9.5.2. Diagnostic Imaging Centers
9.5.3. Others
9.6. Europe Mild Traumatic Brain Injury Treatment Market Attractiveness Index
9.6.1. By Country
9.6.2. By Devices Type
9.6.3. By Technique
9.6.4. By End User
10. Asia Pacific Mild Traumatic Brain Injury Treatment Market Analysis and Forecast, 2019–2027
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. China Mild Traumatic Brain Injury Treatment Market
10.2.2. India Mild Traumatic Brain Injury Treatment Market
10.2.3. Japan Mild Traumatic Brain Injury Treatment Market
10.2.4. Australia and New Zealand Mild Traumatic Brain Injury Treatment Market
10.2.5. South Korea Mild Traumatic Brain Injury Treatment Market
10.2.6. ASEAN Mild Traumatic Brain Injury Treatment Market
10.2.7. Rest of Asia Pacific Mild Traumatic Brain Injury Treatment Market
10.3. Asia Pacific Mild Traumatic Brain Injury Treatment Market, By Devices Type
10.3.1. Imaging Devices
10.3.1.1. Computed Tomography Devices
10.3.1.2. Magnetic Resonance Imaging
10.3.1.3. X-Ray
10.3.1.4. Others
10.3.2. Clinical Examination Devices
10.3.3. Monitoring Devices
10.3.3.1. Invasive Monitoring Devices
10.3.3.2. Non-Invasive Monitoring Devices
10.4. Asia Pacific Mild Traumatic Brain Injury Treatment Market, By Technique
10.4.1. Intracranial Pressure Monitoring (ICP)
10.4.2. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
10.5. Asia Pacific Mild Traumatic Brain Injury Treatment Market, By End User
10.5.1. Hospitals
10.5.2. Diagnostic Imaging Centers
10.5.3. Others
10.6. Asia Pacific Mild Traumatic Brain Injury Treatment Market Attractiveness Index
10.6.1. By Country
10.6.2. By Devices Type
10.6.3. By Technique
10.6.4. By End User
11. Middle East Mild Traumatic Brain Injury Treatment Market, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. GCC Countries Mild Traumatic Brain Injury Treatment Market
11.2.2. Israel Mild Traumatic Brain Injury Treatment Market
11.2.3. Oman Mild Traumatic Brain Injury Treatment Market
11.2.4. Rest of Middle East Mild Traumatic Brain Injury Treatment Market
11.3. Middle East Mild Traumatic Brain Injury Treatment Market, By Devices Type
11.3.1. Imaging Devices
11.3.1.1. Computed Tomography Devices
11.3.1.2. Magnetic Resonance Imaging
11.3.1.3. X-Ray
11.3.1.4. Others
11.3.2. Clinical Examination Devices
11.3.3. Monitoring Devices
11.3.3.1. Invasive Monitoring Devices
11.3.3.2. Non-Invasive Monitoring Devices
11.4. Middle East Mild Traumatic Brain Injury Treatment Market, By Technique
11.4.1. Intracranial Pressure Monitoring (ICP)
11.4.2. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
11.5. Middle East Mild Traumatic Brain Injury Treatment Market, By End User
11.5.1. Hospitals
11.5.2. Diagnostic Imaging Centers
11.5.3. Others
11.6. Middle East Mild Traumatic Brain Injury Treatment Market Attractiveness Index
11.6.1. By Country
11.6.2. By Devices Type
11.6.3. By Technique
11.6.4. By End User
12. Africa Mild Traumatic Brain Injury Treatment Market, By Region
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$Mn) Forecast, By Country
12.2.1. South Africa Mild Traumatic Brain Injury Treatment Market
12.2.2. Egypt Mild Traumatic Brain Injury Treatment Market
12.2.3. North Africa Mild Traumatic Brain Injury Treatment Market
12.2.4. Rest of Africa Mild Traumatic Brain Injury Treatment Market
12.3. Africa Mild Traumatic Brain Injury Treatment Market, By Devices Type
12.3.1. Imaging Devices
12.3.1.1. Computed Tomography Devices
12.3.1.2. Magnetic Resonance Imaging
12.3.1.3. X-Ray
12.3.1.4. Others
12.3.2. Clinical Examination Devices
12.3.3. Monitoring Devices
12.3.3.1. Invasive Monitoring Devices
12.3.3.2. Non-Invasive Monitoring Devices
12.4. Africa Mild Traumatic Brain Injury Treatment Market, By Technique
12.4.1. Intracranial Pressure Monitoring (ICP)
12.4.2. Partial Pressure of Oxygen in Brain Tissue (pBrO2)
12.5. Africa Mild Traumatic Brain Injury Treatment Market, By End User
12.5.1. Hospitals
12.5.2. Diagnostic Imaging Centers
12.5.3. Others
12.6. Africa Mild Traumatic Brain Injury Treatment Market Attractiveness Index
12.6.1. By Country
12.6.2. By Devices Type
12.6.3. By Technique
12.6.4. By End User
13. Recommendation
13.1. Market Strategy
14. Competitive Landscape
14.1. Competition Dashboard
14.2. List and Company Overview of Global Key Players
14.3. Company Profiles
14.3.1. TEVA Pharmaceutical Industries Ltd.
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. Key Developments
14.3.1.5. Business Strategies
14.3.2. Neuren Pharmaceuticals Ltd.
14.3.3. Tenax Therapeutics
14.3.4. IschemixInc
14.3.5. Grace Laboratories LLC.
14.3.6. Silver Creek Pharmaceuticals Inc.
14.3.7. Stemedica Cell Technologies Inc.
14.3.8. NeuroScience Pharmaceuticals
14.3.9. Vasopharm GmbH
14.3.10. AmarantusBioScience Holdings
14.3.11. Banayan Biomarkers Inc.
15. Acronyms
